ME-401, a NOVEL, ORAL, POTENT AND SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3-Kinase P110δ (PI3Kδ) IN EARLY CLINICAL DEVELOPMENT FOR B-Cell LYMPHOID MALIGNANCIES
Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_184
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley